GH

GUARDANT HEALTH INC

CUSIP: 40131M109

Market Cap
-
Sector
Healthcare
Institutional Owners
0
Institutional Value
-

About

Guardant Health, Inc. operates as a leading precision oncology company focused on developing and commercializing liquid biopsies to detect and manage cancer. Through its proprietary blood-based tests, the company provides physicians with critical genomic information to guide treatment decisions and monitor disease progression. Guardant Health holds a significant market position in the medical laboratory industry by offering non-invasive alternatives to traditional tissue biopsies for patients with various stages of cancer.

Institutional Holders

Loading...